UAB "Biofarmacija" Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 6,430,016 |
| 290,294 |
| 895,932 |
| 684,842 |
| 30,918 |
| 51.64 |
| 10.65 |
| 4,476,890 |
| 2,011,953 |
| 2,498,821 |
| 3,988,391 |
| 2024 |
|---|
| 7,653,714 |
| 424,734 |
| 950,188 |
| 813,492 |
| 45,144 |
| 45.54 |
| 10.63 |
| 5,290,382 |
| 1,229,158 |
| 1,216,169 |
| 5,302,048 |
| 2025 |
|---|
| 9,009,626 |
| 489,920 |
| 1,042,306 |
| 862,314 |
| 46,890 |
| 49.81 |
| 9.57 |
| 4,152,696 |
| 2,553,567 |
| 1,549,024 |
| 5,155,248 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 9,009,626 |
| 489,920 |
| 1,042,306 |
| 862,314 |
| 46,890 |
| 49.81 |
| 9.57 |
| 4,152,696 |
| 2,553,567 |
| 1,549,024 |
| 5,155,248 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
9,009,626 €18 % *
Sales per employee (€)
489,920 €15 % *
Profit before tax (€)
1,042,306 €10 % *
Net Profit (€)
862,314 €6 % *
Profit per employee (€)
46,890 €4 % *
Total profitability (%)
49.81 %9.38 % *
Net profitability (%)
9.57 %-9.97 % *
Equity (€)
4,152,696 €-22 % *
Amounts Payable And Liabilities (€)
2,553,567 €108 % *
Non-current Assets (€)
1,549,024 €27 % *
CurrentAssets (€)
5,155,248 €-3 % *
